W Thomas London - JoVE Visualize

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002

Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differencesAlison A Evans, Gang Chen, Eric A Ross, et al.

Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:

Pageof 4

Antiviral Therapy|August 24, 2012

Chronic HBV infection outside treatment guidelines: is treatment needed?Alison A Evans, W Thomas London, Robert G Gish, et al.

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2011

Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysisHui Nie, Alison A Evans, W Thomas London, et al.

Journal of Hepatology|December 17, 2011

Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversionHui Nie, Alison A Evans, W Thomas London, et al.

International Journal of Epidemiology|January 22, 2005

Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort studyGang Chen, Wenyao Lin, Fumin Shen, et al.

Hepatology, Medicine and Policy|October 6, 2018

Hepatitis B knowledge among key stakeholders in Haimen City, China: Implications for addressing chronic HBV infectionChari Cohen, Alison A Evans, Peixin Huang, et al.

The American Journal of Gastroenterology|July 5, 2006

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective studyGang Chen, Wenyao Lin, Fumin Shen, et al.

Cancer Causes & Control : CCC|January 31, 2004

Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese populationRebecca A Harris, Gang Chen, Wen Yao Lin, et al.

Antiviral Research|February 9, 2013

Chronic hepatitis B: what should be the goal for new therapies?Timothy M Block, Robert Gish, Haitao Guo, et al.

Vaccine|February 21, 2015

Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiativeAlison A Evans, Chari Cohen, Peixin Huang, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002

Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differencesAlison A Evans, Gang Chen, Eric A Ross, et al.

Pageof 4